Company

Starling Oncology, Inc.

STLN · CIK 0001799191

SEC FORM 4

$1,946,310.05

Sale of 298,853 shares at $6.5126 per share.

Reporting Person Hively Brad · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001079973-26-001175 · filed 2026-08-24 · View filing →

SEC FORM 4

$78,480.00

Purchase of 12,000 shares at $6.54 per share.

Reporting Person Chernett Jorey · Transaction Code P

Traded Aug 14, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0000921895-26-002203 · filed 2026-08-17 · View filing →